Call for papers - Bioinformatics and chemoinformatics in drug discovery

Guest Editors

George M Spyrou, PhD, The Cyprus Institute of Neurology & Genetics, Cyprus
Vetrivel Umashankar, MSc, MPhil, PGDBI, PhD, Indian Council of Medical Research, India

Submission Status: Open | Submission Deadline: 10 June 2025

BMC Bioinformatics is welcoming submissions to our Collection on Bioinformatics and chemoinformatics in drug discovery. This Collection invites submissions on novel computational or statistical approaches integrating bioinformatics and chemoinformatics in the context of drug discovery and repurposing.

Submit to Collection

Meet the Guest Editors

Back to top

George M Spyrou, PhD, The Cyprus Institute of Neurology & Genetics, Cyprus

Prof George M Spyrou holds the European Research Area Chair in Bioinformatics and is the Head of the Bioinformatics Department (C-BIG) at the Cyprus Institute of Neurology and Genetics (CING). Previously, he worked at the Biomedical Research Foundation of the Academy of Athens (BRFAA) as a Staff Research Scientist and also held the position of Head of the Department of Informatics and New Technologies of BRFAA. He is a Senior IEEE member, member of the IEEE Engineering in Medicine and Biology Society and the IEEE Computer Society, member of the European Virus Bioinformatics Center and the representative of CING in the Network Medicine Alliance. His work focuses on the design and development of computational methods for the discovery of complex patterns of biomarkers, the understanding of the molecular mechanisms underlying diseases, and drug repurposing through network-based analysis and systems bioinformatics.

Vetrivel Umashankar, MSc, MPhil, PGDBI, PhD, Indian Council of Medical Research, India

Dr Umashankar is a Scientist-E (Deputy Director Grade) at ICMR-NIRT, Chennai, with over 20 years of experience in bioinformatics. His expertise spans drug design, microbial genome analysis, peptide therapeutics, and computational bioinformatics. He has published 106 research papers and developed several widely-used bioinformatics tools like ACUA, POAP, PEPVIS etc. He has received significant grants, including RGYI and SERB-DST Early Career Research Awards, BIRD award and contributed significantly to ocular and infectious diseases research. Dr Umashankar has also served in key academic and research roles at Sankara Nethralaya and SRM University and is an active member of several professional societies.

About the Collection

BMC Bioinformatics is welcoming submissions to our Collection on Bioinformatics and chemoinformatics in drug discovery.

Chemoinformatics integrates chemical data with computational tools to enhance drug discovery, repurposing and development. By advancing techniques for exploring molecular interactions, predicting biological activity, and refining pharmacokinetic and toxicity profiles, chemoinformatics has become integral to identifying promising drug candidates and repurposing existing drugs for new therapeutic uses.

This Collection invites submissions on novel computational or statistical approaches integrating bioinformatics and chemoinformatics in the context of drug discovery and repurposing, with a focus on virtual screening, molecular docking and QSAR modeling. We encourage studies that highlight innovative strategies for identifying and validating repurposed drug candidates using these methods.

Image credit: © totojang1977 / Stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research, software and database articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Bioinformatics and chemoinformatics in drug discovery" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.